跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIPRETERAX 4 MG/1,25 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BIPRETERAX 4 MG/1,25 MG COMPRIMIDOS
Approved
STANDARD
BIPRETERAX 4 MG/1,25 MG COMPRIMIDOS
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 10, 2023
Approval ID
6983238c51b15403
Company
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
Type
Standard
Approval Details
Approval Id
6983238c51b15403
Drug Cima Aemps Name
BIPRETERAX 4 MG/1,25 MG COMPRIMIDOS
Register Number
OGYI-T-6831-01IP2
Holder Company Name
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-10-10
Dosage Form
COMPRIMIDO
Dose
4 mg/1,25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
Active Ingredients
INDAPAMIDA
1,25 mg
PERINDOPRIL TERC-BUTILAMINA
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 10, 2023
Approval ID
6983238c51b15403
Type
Standard
Back to CIMA-AEMPS Approvals